327 related articles for article (PubMed ID: 30518103)
21. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
22. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
23. Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Cox AD; Der CJ; Philips MR
Clin Cancer Res; 2015 Apr; 21(8):1819-27. PubMed ID: 25878363
[TBL] [Abstract][Full Text] [Related]
24. Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications.
Kabore AF; Johnston JB; Gibson SB
Curr Cancer Drug Targets; 2004 Mar; 4(2):147-63. PubMed ID: 15032666
[TBL] [Abstract][Full Text] [Related]
25. Physiological modulation approaches to improve cancer chemotherapy : a review.
Kumar R; Kaur M; Silakari O
Anticancer Agents Med Chem; 2014 Jun; 14(5):713-49. PubMed ID: 24117110
[TBL] [Abstract][Full Text] [Related]
26. Specific interaction between Ca2+ and anionic lipids in cancer cells along with apoptosis.
Goto K; Tatsumi K; Nagata T; Komizu Y; Ueoka R
Biol Pharm Bull; 2011; 34(3):439-42. PubMed ID: 21372400
[TBL] [Abstract][Full Text] [Related]
27. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment.
Mader JS; Hoskin DW
Expert Opin Investig Drugs; 2006 Aug; 15(8):933-46. PubMed ID: 16859395
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin cytotoxicity: DNA and plasma membrane targets.
Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT
Curr Med Chem; 2008; 15(26):2656-63. PubMed ID: 18991628
[TBL] [Abstract][Full Text] [Related]
29. Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells.
Deng Z; Gao P; Yu L; Ma B; You Y; Chan L; Mei C; Chen T
Biomaterials; 2017 Jun; 129():111-126. PubMed ID: 28340357
[TBL] [Abstract][Full Text] [Related]
30. Two novel approaches targeting cancer cell membrane for tumor therapy.
Feng Y; Wang B; Cao Y; He R
Med Hypotheses; 2013 Apr; 80(4):380-2. PubMed ID: 23374423
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of apoptosis and roles in cancer development and treatment.
Goldar S; Khaniani MS; Derakhshan SM; Baradaran B
Asian Pac J Cancer Prev; 2015; 16(6):2129-44. PubMed ID: 25824729
[TBL] [Abstract][Full Text] [Related]
32. Editorial: Antitumor alkylphospholipid analogs: a promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment).
Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):495-8. PubMed ID: 24628231
[No Abstract] [Full Text] [Related]
33. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
Hata AN; Engelman JA; Faber AC
Cancer Discov; 2015 May; 5(5):475-87. PubMed ID: 25895919
[TBL] [Abstract][Full Text] [Related]
34. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.
Ralph SJ; Low P; Dong L; Lawen A; Neuzil J
Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044
[TBL] [Abstract][Full Text] [Related]
35. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers.
Jendrossek V; Handrick R
Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):343-53. PubMed ID: 12871080
[TBL] [Abstract][Full Text] [Related]
36. Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy.
Shilova ON; Shilov ES; Lieber A; Deyev SM
J Control Release; 2018 Sep; 286():125-136. PubMed ID: 30030181
[TBL] [Abstract][Full Text] [Related]
37. Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.
Michael JV; Goldfinger LE
Semin Cancer Biol; 2019 Feb; 54():121-130. PubMed ID: 29203271
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria as therapeutic targets for the treatment of malignant disease.
Fulda S; Kroemer G
Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis signaling in tumor therapy.
Fulda S; Debatin KM
Ann N Y Acad Sci; 2004 Dec; 1028():150-6. PubMed ID: 15650241
[TBL] [Abstract][Full Text] [Related]
40. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
